November 15, 2017
RegMed Investors’ (RMi) pre-open indications; flack vest or a checkbook?
November 14, 2017
RegMed Investors’ (RMi) pre-open indications; have you been read in …
November 13, 2017
RegMed Investors’ (RMi) pre-open indications; we are stuck in a trading pit versus an investing suite
November 10, 2017
RegMed Investors’ (RMi) pre-open indications; it’s time for a break …
November 9, 2017
RegMed Investors’ (RMi) pre-open indications; is there a pricing at which a share value’s sustainable
November 8, 2017
RegMed Investors’ (RMi) pre-open indications; a dead week
November 7, 2017
RegMed Investors’ (RMi) pre-open indications; companies’ loyalty to investors has just slipped away
November 6, 2017
RegMed Investors’ (RMi) pre-open indications; be prepared to navigate Q3 reporting
November 3, 2017
RegMed Investors’ (RMi) pre-open indications; never be too long …
November 2, 2017
RegMed Investors’ (RMi) pre-open indications; give me a reason for …
November 1, 2017
RegMed Investors’ (RMi) pre-open indications; Q3 quarterly results set the tone
October 31, 2017
RegMed Investors’ (RMi) pre-open indications; get ready for reporting season
October 30, 2017
RegMed Investors’ (RMi) pre-open indications; don’t get agitated
October 27, 2017
RegMed Investors’ (RMi) pre-open indications; headwinds remain
October 26, 2017
RegMed Investors’ (RMi) pre-open indications; oversold
October 25, 2017
RegMed Investors’ (RMi) pre-open indications; we need to escape the ravages of the downside
October 24, 2017
RegMed Investors’ (RMi) pre-open indications; every company has another side
October 23, 2017
RegMed Investors’ (RMi) pre-open indications; the glass half empty
October 20, 2017
RegMed Investors’ (RMi) pre-open indications; price resilience in a bad market is a positive
October 19, 2017
RegMed Investors’ (RMi) pre-open indications; lot of challenges
October 18, 2017
RegMed Investors’ (RMi) pre-open indications; after many busts in the sector, there has to be a little boom
October 17, 2017
RegMed Investors’ (RMi) pre-open indications; the battle of the oversold versus the overbought
October 16, 2017
RegMed Investors’ (RMi) pre-open indications; what we need to know for today
October 13, 2017
RegMed Investors’ (RMi) pre-open indications; the oversold are undervalued in more ways than one
October 12, 2017
RegMed Investors’ (RMi) pre-open indications; the turning of the herd
4 hours 30 min ago
RMi Pre-opening: Sentiment is fragile
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.